CCCC - C4 Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CCCC is currently covered by 4 analysts with an average price target of $10.33. This is a potential upside of $8.07 (357.08%) from yesterday's end of day stock price of $2.26.

C4 Therapeutics 's activity chart (see below) currently has 64 price targets and 53 ratings on display. The stock rating distribution of CCCC is 28.57% HOLD and 71.43% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.21% with an average time for these price targets to be met of 60.55 days.

Highest price target for CCCC is $10, Lowest price target is $3.5, average price target is $7.88.

Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 23-Sep-2025. First documented stock forecast 27-Oct-2020.

Currently out of the existing stock ratings of CCCC, 2 are a HOLD (28.57%), 5 are a BUY (71.43%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$10

$7.39 (283.14%)

$8

1 months 12 days ago
(23-Sep-2025)

4/6 (66.67%)

$7.41 (286.10%)

147

Buy

$10

$7.39 (283.14%)

$8

1 months 12 days ago
(23-Sep-2025)

0/4 (0%)

$7.41 (286.10%)

Buy

$8

$5.39 (206.51%)

$12

2 months ago
(04-Sep-2025)

4/10 (40%)

$5.33 (199.63%)

102

Hold

$3.5

$0.89 (34.10%)

$4

8 months 1 days ago
(03-Mar-2025)

1/3 (33.33%)

$1.1 (45.83%)

196

Buy

$14

$11.39 (436.40%)

$15

1 years 8 months ago
(04-Mar-2024)

1/3 (33.33%)

$3.32 (31.09%)

29

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CCCC (C4 Therapeutics ) average time for price targets to be met?

On average it took 60.55 days on average for the stock forecasts to be realized with a an average price target met ratio 36.21

Which analyst has the current highest performing score on CCCC (C4 Therapeutics ) with a proven track record?

DEREK ARCHILA

Which analyst has the most public recommendations on CCCC (C4 Therapeutics )?

Derek Archila works at WELLS FARGO and has 2 price targets and 3 ratings on CCCC

Which analyst is the currently most bullish on CCCC (C4 Therapeutics )?

Leah Rush Cann with highest potential upside - $76.14

Which analyst is the currently most reserved on CCCC (C4 Therapeutics )?

Matthew Luchini with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?